1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Analysis of the US Autoimmune Disease Diagnostics Market 

Analysis of the US Autoimmune Disease Diagnostics Market 

  • February 2016
  • -
  • Frost & Sullivan
  • -
  • 59 pages

Analysis of the US Autoimmune Disease Diagnostics Market : Systemic Autoimmune Diseases Spur a Double-digit Market Growth Rate of 14.2%

According to the National Institute of Health (NIH), there are more than 80 types of autoimmune diseases, of which less than 30 are diagnosable. Being 1 of the top 10 causes of death in the United States, there is a critical need in the market for the diagnosis and the treatment of both systemic diseases, such as lupus and rheumatoid arthritis, as well as localized diseases, such as celiac, IBD, IBS, and Hashimoto's. Systemic diseases dominate the market due to their high prevalence in the United States and also because of the market participation of large diagnostics companies, such as Inova Diagnostics, Siemens Healthcare, Abbott Diagnostics, and Beckman Coulter. The localized disease segment is the fastest-growing, mainly due to celiac, as gluten intolerance in the United States is increasing at an exponential rate.

Key Predictions: US Autoimmune Disease Diagnostics Market

Total Autoimmune Disease Diagnostics Market: Key Predictions, US, 2015

The market generated a revenue of $ million in 2015 and is expected to reach $ million in 2020, at a compound annual growth rate (CAGR) of %, spurred by localized diseases, such as celiac, which is expected to grow at % in the United States. Systemic diseases, such as systemic lupus erythematosus (SLE) and RA will remain the highest revenue contributors to the market.

Companies that have multiplexing systems and sensitive nucleic acid amplification technique (NAT)-based assays will be able to meet the need for accurate diagnosis and quick turnaround time when compared to companies that use automation systems like enzymelinked immunosorbent assay (ELISA), which will be reflected in the increasing adoption of NAT-based platforms.

Despite Theranos Inc.’s failure at direct-to-consumer tests, the model still persists in the industry. Gluten allergy tests can be purchased directly by consumers, which will disrupt the lab testing market through test volume revenue loss.

The top market shareholders will expand their revenue by investing in other revenue channels by partnering with pharmaceutical companies for companion diagnostics. Autoimmune diagnostics will no longer be considered a niche market. In vitro diagnostic companies that are established with automation devices will expand their portfolio to cover this market.
An increasing number of platforms will include the genetic analysis component in addition to immunoassays. The accuracy of the results offered by these systems will be increasingly utilized for therapy selection for the personalized treatment of autoimmune disorders.

Table Of Contents

Analysis of the US Autoimmune Disease Diagnostics Market 
1 ANALYSIS OF THE US AUTOIMMUNE DISEASE DIAGNOSTICS MARKET

Executive Summary
1 Scope and Segmentation
2 Key Predictions: US Autoimmune Disease Diagnostics Market
3 Current Trends in the Autoimmune Disease Diagnostics Market
4 Autoimmune Disease Diagnostics Market—Overview
5 Key Companies to Watch

Competitive Overview
1 Ecosystem of the Autoimmune Disease Diagnostics Market
2 Significance of the Autoimmune Disease Diagnostics Market
3 Significance of the Autoimmune Disease Diagnostics Market—Prevalence Rates
4 Competitive Landscape
5 Key Diseases and Available Solutions in the US Market
6 Key Diseases and Available Solutions in the US Market
7 LDTs—Role in Autoimmune Disease Diagnostics
8 Segment Lifecycle Analysis by Disease
9 Overall Market Forecast
10 Overall Disease Segment Share
11 Competitive SWOT Analysis by Company
12 Competitive SWOT Analysis by Company

Growth Opportunities
1 Where do the Opportunities Lie in this Market?
2 Pharma and Diagnostics Business Integration
3 Autoimmune Diagnostics Companies are Uniting with Pharmaceuticals to Diversify Revenue Channels
4 Direct-to-Consumer Market: The Risk and The Opportunity

Localized Disease Diagnostics Segment
1 Localized Disease Diagnostics Segment Revenue
2 Growth Rate by Localized Autoimmune Diseases
3 Competitive Value Matrix—Localized Disease Diagnostics Segment
4 Autoimmune Tests—Role in Patient Continuum

Systemic Disease Diagnostics Segment
1 Systemic Disease Diagnostics Segment Revenue
2 Growth Rate by Systemic Autoimmune Diseases
3 Competitive Value Matrix—Systemic Disease Diagnostics Segment
4 Autoimmune Tests—Role in Patient Continuum

Conclusion
1 Key Conclusions and Future Outlook
2 Legal Disclaimer

Appendix—List of LDTs
1 Celiac Disease-specific LDT Assays
2 Chron's Disease-specific LDT Assays
3 RA-specific LDT Assays
4 Lupus-specific LDT Assays
5 IBD/IBS-specific LDT Assays
6 Others
7 Learn More—Next Steps
8 List of Exhibits
9 List of Exhibits
10 List of Exhibits

The Frost and Sullivan Story
1 The Frost and Sullivan Story
2 Value Proposition: Future of Your Company and Career
3 Global Perspective
4 Industry Convergence
5 360º Research Perspective
6 Implementation Excellence
7 Our Blue Ocean Strategy

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Phototherapy Equipment Market by Type, Application, End-user, Geography - Global Forecast to 2021

Phototherapy Equipment Market by Type, Application, End-user, Geography - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global phototherapy equipment market is projected to reach USD 583.4 million by 2021, growing at a CAGR of 4.5% during the forecast period of 2016 to 2021. This market is primarily driven by the huge ...

Antinuclear Antibody Test Market by Product, Technique, Disease, End User - Forecast to 2021

Antinuclear Antibody Test Market by Product, Technique, Disease, End User - Forecast to 2021

  • $ 5650
  • Industry report
  • September 2016
  • by MarketsandMarkets

The global antinuclear antibody (ANA) testing market is expected to reach USD 1,476.1 million by 2021 from USD 823.5 million in 2016, at a CAGR of 12.4%. The global ANA testing market is segmented based ...

Interstitial Cystitis  - Market Insights, Epidemiology and Market Forecast-2023

Interstitial Cystitis  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Interstitial Cystitis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.